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Abstract
Background: Chronic food restriction augments the rewarding effect of centrally administered
psychostimulant drugs and this effect may involve a previously documented upregulation of D-1
dopamine receptor-mediated MAP kinase signaling in nucleus accumbens (NAc) and caudate-
putamen (CPu). Psychostimulants are known to induce striatal glutamate release, and group I
metabotropic glutamate receptors (mGluR) have been implicated in the cellular and behavioral
responses to amphetamine. The purpose of the present study was to evaluate whether chronic
food restriction increases striatal MAP kinase signaling in response to the group I mGluR agonist,
DHPG.
Results: Western immunoblotting was used to demonstrate that intracerebroventricular (i.c.v.)
injection of DHPG (500 nmol) produces greater activation of ERK1/2 and CREB in CPu and NAc
of food-restricted as compared to ad libitum fed rats. Fos-immunostaining induced by DHPG was
also stronger in CPu and NAc core of food-restricted relative to ad libitum fed rats. However, i.c.v.
injection of saline-vehicle produced greater activation of ERK1/2 and CREB in CPu and NAc of
food-restricted relative to ad libitum fed rats, and this difference was not seen when subjects
received no i.c.v. injection prior to sacrifice. In addition, although DHPG activated Akt, there was
no difference in Akt activation between feeding groups. To probe whether the augmented ERK1/2
and CREB activation in vehicle-injected food-restricted rats are mediated by one or more GluR
types, effects of an NMDA antagonist (MK-801, 100 nmol), AMPA antagonist (DNQX, 10 nmol),
and group I mGluR antagonist (AIDA, 100 nmol) were compared to saline-vehicle. Antagonist
injections did not diminish activation of ERK1/2 or CREB.
Conclusions: These results indicate that a group I mGluR agonist induces phosphorylation of Akt,
ERK1/2 and CREB in both CPu and NAc. However, group I mGluR-mediated signaling may not be
upregulated in food-restricted rats. Rather, a physiological response to "i.c.v. injection stress" is
augmented by food restriction and appears to summate with effects of the group I mGluR agonist
in activating ERK1/2 and CREB. While the augmented cellular response of food-restricted rats to
i.c.v. injection treatment represents additional evidence of enhanced CNS responsiveness in these
subjects, the functional significance and underlying mechanism(s) of this effect remain to be
elucidated.
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Background
Chronic food restriction increases central sensitivity to
rewarding and motor-activating effects of psychostimu-
lants and direct dopamine receptor agonists [1]. Corre-
sponding adaptive changes at the cellular level include
increased psychostimulant-induced DA release in nucleus
accumbens core [2], and upregulation of D-1 DA receptor-
mediated MAP kinase signaling in dorsal and ventral stria-
tum, with consequent increased activation of CREB and
the immediate early gene, c-fos [3,4]. Changes in striatal
glutamate receptor function have not been investigated
but are of interest in light of findings that (i) psychostim-
ulants induce striatal glutamate release [5-7], (ii) amphet-
amine-induced activation of striatal MAP kinase, CREB,
and c-fos is attenuated by a group I metabotropic gluta-
mate receptor antagonist [8], and (iii) the augmented
effects of striatal D-1 receptor stimulation in food-
restricted rats include hyperphosphorylation of the
NMDA receptor NR1 subunit [9].
The group I mGluRs (mGluR1/5) are of particular interest.
Group I mGluRs are densely expressed in striatal medium
spiny neurons [10] and activate phospholipase C, result-
ing in hydrolysis of phosphoinositides and activation of
Ca2+-dependent signaling cascades [11]. The group I
mGluR agonist, DHPG, increases the phosphorylation of
extracellular signal-regulated kinase (ERK) and the tran-
scription factor CREB when infused into dorsal striatum
[12], as do cocaine injected systemically and the D-1 ago-
nist SKF-82958 injected into the lateral ventricle [4,13].
DHPG also elicits hyperlocomotion resembling that
induced by DA receptor agonists, and the effect is not
attenuated by the D-1 DA receptor antagonist, SCH23390
[10]. It is therefore possible that glutamate and group I
mGluR function contribute to the changes in psychostim-
ulant-induced behavioral responses and striatal cell sign-
aling in food-restricted subjects. The purpose of the first
experiment of this study was to compare dorsal and ven-
tral striatal cell signaling in response to intracerebroven-
tricular (i.c.v.) administration of the group I mGluR
agonist, DHPG, in ad libitum fed and food-restricted rats.
A dose of 500 nmol was used based on pilot work and
published reports indicating that this dose is sufficient to
exert behavioral effects [14] and stimulate PI hydrolysis
[11] while being below threshold for producing convul-
sive behavior [15]. A second experiment was based on
results of the first experiment and sought to elucidate the
observed increase in striatal ERK1/2 and CREB phosphor-




In both the caudate-putamen and nucleus accumbens
ERK1/2 phosphorylation was increased by food restric-
tion (Cpu: F1,18 = 10.8, p < .005; NAc: F1,18 = 8.2, p < .01)
and by DHPG injection (Cpu: F1,18 = 6.6, p < .02; NAc:
F1,18 = 10.6, p < .005). However, there was no interaction
between feeding condition and drug treatment in either
brain region (Cpu: F1,18 = 0.6; NAc: F1,18 = 0.3). This anal-
ysis supports the impression (see Figures 1 &2, top panel)
that food restriction did not actually increase the group I
mGluR-mediated response to DHPG; rather, increased
signaling in the food-restricted group, irrespective of i.c.v.
injection treatment, appears to have summated with
DHPG to produce a greater net effect in the food-restricted
than ad libitum fed group. An identical pattern of results
was obtained for CREB phosphorylation (Figures 1 &2
center panel; Cpu: Fdiet; 1,18 = 6.2, p < .025; Fdrug; 1,18 = 3.9,
p = .06; Fdiet × drug; 1,18 = 1.2; NAc: Fdiet; 1,18 = 12.9, p < .0025;
Fdrug; 1,18 = 15.3, p < .001; Fdiet × drug; 1,18 = 2.7, p > .10).
Interestingly, Akt phosphorylation was induced by DHPG
but did not differ between food-restricted and ad libitum
fed groups in either the Cpu (Fdrug; 1,18 = 4.5, p < .05; Fdiet;
1,18 = 0.4; Fdiet × drug; 1,18 = 0.4) or NAc (Fdrug; 1,18 = 12.7, p <
.0025; Fdiet; 1,18 = 0.4; Fdiet × drug; 1,18 = 2.4, p > .10; Figures 1
&2 bottom panel).
In previous studies, striatal Fos-immunostaining was
greater in food-restricted relative to ad libitum fed rats
injected i.c.v. with d-amphetamine or the D-1 DA receptor
agonist SKF-82958, but not saline-vehicle [3,16]. There-
fore, in a small sample of ad libitum fed and food-
restricted subjects, brains were processed for Fos-immu-
nostaining and revealed stronger DHPG-induced staining
in CPu (t(7) = 3.6, p < .01) and NAc core (t(7) = 2.8 p <
.025) but not NAc shell (t(7) = 1.1) of food-restricted, rel-
ative to ad libitum fed, subjects (see Figure 3).
During the period between DHPG injection and sacrifice,
rats, which remained in their home cages, did not display
any obvious behavioral responses to the drug.
Experiment 2
In rats without lateral ventricular cannulas that received
no injection treatment prior to sacrifice, ERK1/2 phos-
phorylation did not differ between feeding groups (Figure
4; Cpu: t(8) = 1.2; NAc: t(8) = 1.0), nor did CREB phos-
phorylation (Cpu: t(8) = 1.2; NAc t(8) = 0.1).
In food-restricted rats injected with GluR antagonists prior
to sacrifice, neither ERK1/2 nor CREB phosphorylation
differed from that observed in food-restricted rats injected
with saline-vehicle (Figure 5).
Discussion
Adding to the results of Choe and Wang who demon-
strated DHPG-induced activation of ERK1/2 and CREB in
dorsal striatum [12], the present study has demonstratedBMC Neuroscience 2004, 5:50 http://www.biomedcentral.com/1471-2202/5/50
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Effects of DHPG on activation of ERK1/2, CREB and Akt in Caudate-Putamen Figure 1
Effects of DHPG on activation of ERK1/2, CREB and Akt in Caudate-Putamen Ad libitum fed and food-restricted 
rats received i.c.v. injections of DHPG (500 nmol) or saline vehicle prior to sacrifice. Lysates were immunoblotted with anti-
phospho ERK1/2 or anti-ERK1/2 (top), anti-phospho-CREB or anti-CREB (center), or anti-phospho-Akt or anti-Akt (bottom) 
antibodies. Following densitometry, intensities of bands corresponding to phosphorylated proteins were divided by intensities 
of the corresponding total protein bands to correct for small differences in protein loading. Results (mean ± S.E.M.) are 
expressed in comparison to the normalized control, which was defined as the ad libitum fed group injected with vehicle. 
Graphed results are displayed with representative immunoblots.BMC Neuroscience 2004, 5:50 http://www.biomedcentral.com/1471-2202/5/50
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Effects of DHPG on activation of ERK1/2, CREB and Akt in Nucleus Accumbens Figure 2
Effects of DHPG on activation of ERK1/2, CREB and Akt in Nucleus Accumbens Ad libitum fed and food-restricted 
rats received i.c.v. injections of DHPG (500 nmol) or saline vehicle prior to sacrifice. Lysates were immunoblotted with anti-
phospho ERK1/2 or anti-ERK1/2 (top), anti-phospho-CREB or anti-CREB (center), or anti-phospho-Akt or anti-Akt (bottom) 
antibodies. Following densitometry, intensities of bands corresponding to phosphorylated proteins were divided by intensities 
of the corresponding total protein bands to correct for small differences in protein loading. Results (mean ± S.E.M.) are 
expressed in comparison to the normalized control, which was defined as the ad libitum fed group injected with vehicle. 
Graphed results are displayed with representative immunoblots.BMC Neuroscience 2004, 5:50 http://www.biomedcentral.com/1471-2202/5/50
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DHPG-induced activation of ERK/12 and CREB in both
CPu and NAc following lateral ventricular infusion. While
i.c.v. injection allows for the possibility that these effects
were not directly mediated by striatal group I mGluRs, the
proximity of striatum to the lateral ventrical and the high
density of mGluRs in these structures support the likeli-
hood of direct effects. Direct effects are also supported by
the observed activation of Akt which mediates group I
mGluR signal transduction [17].
As previously seen in rats challenged with the D-1
dopamine receptor agonist, SKF-82958, DHPG-induced
activation of ERK1/2, CREB and c-Fos were greater in
food-restricted than ad libitum fed rats. However, the pat-
tern of results in this study – i.e. augmented ERK1/2 and
CREB activation in food-restricted rats injected with vehi-
cle, and no difference in Akt activation between feeding
groups – suggests that group I mGluR signaling was not
Effects of DHPG on Fos-like immunostaining in Caudate- Putamen and Nucleus Accumbens core and shell Figure 3
Effects of DHPG on Fos-like immunostaining in Cau-
date-Putamen and Nucleus Accumbens core and 
shell Mean (±S.E.M.) bilateral number of c-Fos immunoreac-
tive (IR) cells within caudate-putamen (CPu) at coronal levels 
+1.7 and -0.3 mm (combined) and nucleus accumbens (Nac) 
core and shell at coronal level +1.5 mm in relation to 
bregma. Ad libitum fed and food-restricted rats were 
injected i.c.v. with DHPG (500 nmol) 90 min prior to per-
fusion. *p < .025, **p < .01 compared to ad libitum fed rats. 
Representative digital photomicrographs depicting Fos-like 
immunoreactivity in NAc of ad libitum fed (left) and food-
restricted (right) rats are included. LV = lateral ventricle; AC 
= anterior commissure.
Basal levels of phospho-ERK1/2 and -CREB in Caudate-Puta- men and Nucleus Accumbens Figure 4
Basal levels of phospho-ERK1/2 and -CREB in Cau-
date-Putamen and Nucleus Accumbens Ad libitum fed 
and food-restricted rats that were not implanted with i.c.v. 
cannulas were sacrificed without receiving experimental 
treatment. Lysates were immunoblotted with anti-phospho 
ERK1/2 or anti-ERK1/2, and anti-phospho-CREB or anti-
CREB antibodies. Following densitometry, intensities of 
bands corresponding to phosphorylated proteins were 
divided by intensities of the corresponding total protein 
bands to correct for small differences in protein loading. 
Results (mean ± S.E.M.) for caudate-putamen (top) and 
nucleus accumbens (bottom) are expressed in comparison to 
the normalized control, which was defined as the ad libitum 
fed group.BMC Neuroscience 2004, 5:50 http://www.biomedcentral.com/1471-2202/5/50
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Effects of Glutamate Receptor Antagonists on Activation of ERK1/2 and CREB in Caudate-Putamen and Nucleus Accumbens of  Food-Restricted Rats Figure 5
Effects of Glutamate Receptor Antagonists on Activation of ERK1/2 and CREB in Caudate-Putamen and 
Nucleus Accumbens of Food-Restricted Rats Food-restricted rats received i.c.v. injections of either saline vehicle, the 
AMPA antagonist DNQX (10 nmol), the group I mGluR antagonist AIDA (100 nmol), or NMDA antagonist MK-801 (100 
nmol) prior to sacrifice. Lysates were immunoblotted with anti-phospho ERK1/2 or anti-ERK1/2 (top) and anti-phospho-CREB 
or anti-CREB (bottom) Following densitometry, intensities of bands corresponding to phosphorylated proteins were divided 
by intensities of the corresponding total protein bands to correct for small differences in protein loading. Results (mean ± 
S.E.M.) for caudate-putamen (left in each figure) and nucleus accumbens (right in each figure) are expressed in comparison to 
the normalized control, which was defined as the group injected with saline vehicle.BMC Neuroscience 2004, 5:50 http://www.biomedcentral.com/1471-2202/5/50
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enhanced. Rather, a cellular-activating effect of the injec-
tion procedure was enhanced by food restriction and
summated with the effect of DHPG. This response of vehi-
cle-injected subjects was clearly a response to some aspect
of the i.c.v. injection procedure because similarly food-
restricted rats that were not challenged in any way prior to
sacrifice displayed levels of pERK1/2 and pCREB that were
essentially identical to those of ad libitum fed rats. Fur-
thermore, the augmented activation of ERK1/2 and CREB
in vehicle-injected food-restricted rats was not mediated
by Akt because Akt, though activated by DHPG, did not
differ between food-restricted and ad libitum fed rats
injected with vehicle or DHPG.
Attribution of the augmented DHPG-induced ERK1/2 and
CREB phosphorylation to a "nonspecific" response to
i.c.v. injection distinguishes the group I mGluR from the
D-1 DA receptor. Although a modestly enhanced ERK
response to i.c.v. vehicle infusion was seen in the NAc of
food-restricted rats in the prior study, the dramatically
increased activation of ERK1/2 and CREB by SKF-82958
in CPu and NAc was dissociable from any response to the
injection procedure [4]. Even mild stressors are known to
stimulate DA [18] and Glu [19,20] release in striatum,
and it is possible that food-restriction augments this phys-
iological response or the cell signaling induced by it.
Because the ionotropic (AMPA and NMDA) as well as
group I mGluRs are abundant in striatum and all three
receptor types mediate MAP kinase signaling [12,21,22],
corresponding antagonists were injected i.c.v. and com-
pared to vehicle. It was reasoned that if the physiological
response to the injection procedure involves one of these
GluRs, ERK1/2 and CREB phosphorylation would be
decreased, relative to vehicle, in the group(s) receiving the
corresponding antagonist. The MK-801 treatment was
also a potential probe for mediation by D-1 DA receptors
because D-1 DA agonist-induced activation of ERK1/2
and CREB are dependent on the NMDA receptor in food-
restricted subjects [9]. Results of this test did not provide
support for mediation by one of the GluR types. Because
only one dose of each antagonist was used, these results
must be considered preliminary. However, considering
the proximity of striatum to the lateral ventricle, and the
fact that the doses used have exerted measurable cellular,
physiological or behavioral effects in other studies [23-26]
there is some doubt about involvement of GluRs in the
effect of "injection stress".
An interesting possibility to consider is mediation of the
response by brain-derived neurotrophic factor (BDNF).
Food-restricted rats have elevated striatal BDNF levels
which appear to be involved in an enhanced neuroprotec-
tive response to diverse insults [27]. BDNF activates
striatal ERK1/2 which, unlike glutamate-induced activa-
tion of Akt, ERK1/2 and CREB is not blocked by a PI 3-
kinase inhibitor [21]. It is therefore possible that an
enhanced BDNF-mediated activation of ERK1/2 and
CREB in food-restricted rats represents a neuroprotective
response to intraventricular infusion.
Conclusions
The present results indicate that a group I mGluR agonist
activates Akt, ERK1/2 and CREB in both the CPu and NAc.
Further, activation of ERK1/2, CREB, and c-Fos are
stronger in food-restricted than in ad libitum fed rats. The
augmented response is not attributed to increased Group
I mGluR function but, instead, to an augmented response
of food-restricted rats to the i.c.v. injection procedure.
Some evidence casting doubt on attribution of the latter
response to GluRs was obtained. It will be of interest to
evaluate whether striatal MAPK signaling in food-
restricted rats is generally augmented in response to stres-
sors or whether this response is peculiar to i.c.v. infusion.
In addition, it will be of interest to evaluate whether this




All experimental procedures were approved by the New
York University School of Medicine Institutional Animal
Care and Use Committee and were performed in accord-
ance with the "Principles of Laboratory Animal Care"
(NIH publication number 85-23, revised 1996).
Subjects were male Sprague-Dawley rats (375–425 g)
housed individually in plastic cages with free access to
food and water except when food restriction conditions
applied. Animals were maintained on a 12-h light/dark
cycle, with lights on at 07:00 h. Rats were anesthetized
with ketamine (100 mg/kg; i.p.) and xylazine (10 mg/kg;
i.p.) and stereotaxically implanted with a 26-gauge guide
cannula (Plastics One, Roanoke, VA USA) in the right lat-
eral ventricle. The cannula was permanently affixed to the
skull by flowing dental acrylic around it and four sur-
rounding mounting screws. Patency of the guide cannula
was maintained with an occlusion stylet. Several days after
surgery, cannula placements were confirmed by demon-
stration of a vigorous and short latency (i.e. <60 s) drink-
ing response to 50 ng of angiotensin II.
Food restriction and habituation
Seven days following surgery, half the subjects were put
on a food restriction regimen whereby a single 10 g meal
of Purina (Gray Summit, MO USA) rat chow was delivered
at approximately 17:00 h each day. Rats continued to have
ad libitum access to water. Once body weight had declined
by 20–25% (approximately 15 days) daily food allot-
ments were titrated for an additional week to maintain
stable body weight. During the 3 weeks required for food-BMC Neuroscience 2004, 5:50 http://www.biomedcentral.com/1471-2202/5/50
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restricted rats to attain and stabilize at target body
weights, all rats were habituated, on five occasions, to the
handling and injection procedures to be employed on the
terminal day of the experiment.
Drug treatment
In Experiment 1, six food-restricted and six ad libitum fed
rats received i.c.v injections of sterile 0.9% saline (5 µl).
Six food-restricted and six ad libitum fed rats received i.c.v
injections of the group I metabotropic glutamate receptor
agonist, DHPG (500 nmol in 5 µl; Tocris Cookson, Ellis-
ville, MO, USA). An additional five food-restricted and
four ad libitum fed rats received i.c.v. injections of DHPG
and brains were processed for Fos-immunostaining. In
Experiment 2, six unoperated food-restricted rats and six
unoperated ad libitum fed rats were prepared and habitu-
ated as above and received no unusual handling or drug
injection on the terminal day of the experiment. In the
second part of Experiment 2, twenty four food-restricted
rats with lateral ventricular cannulas were prepared and
habituated as in Experiment 1. On the terminal day of the
experiment, six were injected i.c.v. with saline vehicle (5.0
µl), six were injected with the AMPA glutamate receptor
antagonist, DNQX (10 nmol; Sigma-Aldrich, St. Louis,
MO), six were injected with the NMDA glutamate receptor
antagonist, MK-801 (100 nmol; Sigma-Aldrich), and six
were injected with the group I mGluR antagonist, AIDA
(100 nmol; Tocris Cookson). Antagonist doses were cho-
sen on the basis of prior findings [e.g. [23,26,28]] and/or
being just below threshold for producing noticeable
motoric abnormalities. For i.c.v injection, solutions were
loaded into a 30 cm length of PE-50 tubing attached at
one end to a 250-µl Hamilton syringe filled with distilled
water and at the other end to a 33-gauge injector cannula
which extended 1.0 mm beyond the implanted guide. The
5.0 µl injection volume was delivered over a period of 95
s. One minute following injection, internal cannulas were
removed, stylets replaced, and animals were returned to
home cages.
Lysate preparation
Prior studies have indicated that MAP kinase activation is
transient and the optimal time-point to study phosphor-
ylation of ERK 1/2 after physiological or pharmacological
treatment is 15–20 min [29]. Therefore, all rats, except the
twelve unoperated/uninjected rats, were killed 20 min
after injection by brief exposure to CO2  followed by
decapitation. The twelve unoperated/uninjected rats were
simply removed from home cages and exposed to CO2 fol-
lowed by decapitation. Brains were rapidly removed and
immediately frozen in powdered dry ice. Five hundred-
micrometer sections were cut using an IEC Minotome cry-
ostat, and CPu and NAc were micropunched, under an
Olympus dissecting microscope, from a series of 8 consec-
utive frozen sections. The tissue was then homogenized in
10 volumes of 50 mM Tris-HCl, pH 7.5 containing 50 mM
NaCl, 5 mM EDTA, 1 mM EGTA, 1 mM Na3VO4, 40 mM
β-glycerophosphate, 50 mM NaF and 5 mM Na4P2O7, 1%
Tx-100, 0.5 µM okadaic acid, 0.5% sodium deoxycholate
and 0.1% SDS, followed by centrifugation and protein
determination using BCA reagent kit as described by the
manufacturer (Pierce) Supernatants were mixed with 5 ×
SDS-PAGE sample buffer, boiled for 5 min, cooled on ice
and kept at -80°C until future use.
Western blotting
Protein (10–30 µg per lane) was separated by electro-
phoresis on precast 10% polyacrylamide gels (Cambrex,
East Rutherford, NJ, USA). Precision Plus protein standard
molecular weight markers (Bio-Rad, Hercules, CA, USA)
were also loaded to assure complete electrophoretic trans-
fer and to estimate the size of bands of interest. The gels
were transferred to nitrocellulose membrane (Osmonics)
for 2 h, with a constant voltage of 100 volts. Membranes
were blocked for 1 hr at room temperature with blocking
buffer, 5% non fat dry milk in 50 mM Tris-HCl, pH 7.5
containing 150 mM NaCl and 0.1% Tween 20 (TBS-T),
then probed overnight at 4°C using primary monoclonal
antibodies for phospho-(Thr202/Tyr204)-p44/42 ERK1/2
(mouse monoclonal, 1:2000; Cell Signaling, Beverly, MA,
USA), or polyclonal antibodies for phospho-Akt (Ser 473)
(rabbit polyclonal, 1:1000 dilutuion, Cell Signaling), and
phospho (Ser 133) CREB (rabbit polyclonal, 1:2000;
Upstate Biotechnology, Lake Placid, NY, USA). Total lev-
els of ERK1/2, Akt and CREB were detected on the same
blots using anti-rabbit p42/44 ERK1/2 antibody 1:2000,
(Cell Signaling), anti-rabbit total Akt (1:2000 dilution,
Cell Signaling), or anti-rabbit CREB antibody (1:2000
dilution, Calbiochem). After detection of phosphorylated
ERK1/2, phospho-Akt and CREB blots were stripped with
25 mM Glycine, pH 2.0 containing 1% SDS for 30 min at
room temperature, washed six times in TBS-T buffer,
blocked in blocking buffer for 1 h and then incubated
overnight at 4°C in total ERK1/2, total Akt or CREB anti-
body. After probing with primary antibodies and washing
with TBS-T buffer (3 × 5 min), membranes were incubated
with 1:2000 dilution horseradish peroxidase conjugated
anti-mouse or 1: 2000 dilution anti-rabbit IgG (Cell Sign-
aling). Proteins were visualized using a chemilumines-
cense ECL kit (Pierce). Densitometric analysis of the
bands was performed using NIH image software. Phos-
pho-p42/44 MAPK, phospho Akt and phospho CREB val-
ues were normalized to total p42/44 MAPK, Akt and
CREB values respectively.
Immunohistochemistry
Ninety min after DHPG injection rats were anesthetized
with sodium pentobarbital (50.0 mg/kg,i.p.) and tran-
scardially perfused with isotonic phosphate buffered
saline (PBS) followed by 4% paraformaldehyde in PBS.BMC Neuroscience 2004, 5:50 http://www.biomedcentral.com/1471-2202/5/50
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Brains were then removed and maintained in 20% sucrose
at 4°C for 48 h. Forty µm sections were cut on an IEC
Minotome cryostat and collected in a cryoprotective solu-
tion. Fos immunostaining was carried out using a rabbit
polyclonal c-Fos antiserum (Oncogene Science-Calbio-
chem, La Jolla, CA) and the avidin-biotin peroxidase com-
plex (ABC; Vector laboratories).
Sections were washed in 1% sodium borohydride fol-
lowed by PBS and incubated for 2 hrs in 4% normal goat
serum plus 1% BSA in PBS containing 0.2% Triton X-100
(Sigma-Aldrich) to block nonspecific binding. This was
followed by incubation, overnight, with rabbit polyclonal
c-fos antiserum (1:5000 dilution). Following several PBS
washes, sections were incubated with a secondary antise-
rum (Vector, Burlingame, CA) for 60 min and subse-
quently reacted with avidin-biotin complex (ABC)
(Vector). The peroxidase reaction was visualized with a
chromogen solution containing 100 mM nickel sulfate,
125 mM sodium acetate, 10 mM imidazole, 0.03% diami-
nobenzidine (DAB), and 0.01% hydrogen peroxide at pH
6.5. Sections were then mounted on chrome-alum coated
slides, dehydrated, and coverslipped.
Objective counting of c-Fos positive cells in CPu at coro-
nal levels +1.7 and -0.3 mm, and NAc core and shell at
coronal level +1.5 mm in relation to bregma [30] was
accomplished with a light microscope (Olympus, CK2)
equipped with a Sony XC-77 video camera module
coupled to an MCID image analysis system (Imaging
Research Inc., St. Catherines, Canada). For each region,
bilateral grain counts from three to five consecutive sec-
tions were measured to arrive at an average bilateral value
per rat. Because results obtained from anterior and poste-
rior levels of CPu were essentially the same, results from
the two levels were combined and averaged for each rat.
Data analysis
For each Western blot, film exposure time was set as
needed to visualize distinct bands in the control samples
of each experiment. Immunoblots were analyzed using
NIH imaging software. For each blot, relative phospho-
protein levels were calculated from the ratio of optical
density of the phosphorylated protein/total protein to
correct for small differences in protein loading. In addi-
tion, tubulin levels were analyzed in several representative
gels and no differences were observed between treatment
groups. Results were expressed by comparison to the nor-
malized control, which in Experiment 1 was defined as
the ad libitum fed group injected with vehicle. In the first
part of Experiment 2, unoperated/uninjected ad libitum
fed rats served as control. In the second part of Experiment
2, food-restricted rats injected with i.c.v. saline vehicle
served as control. Differences between treatment condi-
tions in Experiment 1 were analyzed by two-way analysis
of variance (ANOVA; feeding condition × injection treat-
ment). Differences between treatment conditions in the
first and second parts of Experiment 2 were analyzed by
student's t-test and one-way ANOVA, respectively.
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